SUGI HOLDINGS CO.,LTD. (7649) Stock Price

Market cap
¥682.6B
P/E ratio
19.8x
Japanese healthcare conglomerate operating drugstores, pharmacies, and medical services through 34 subsidiaries including Sugi Pharmacy and Sugi Medical.

Price and Volume

Market Cap

Subscribe to premium to access
Market Cap.

Check pricing

PER

Subscribe to premium to access
PER.

Check pricing

PBR

Business Overview

Sugi Holdings is composed of 34 subsidiaries, including Sugi Pharmacy, Sugi Medical, S Trading, and I&H, along with 4 affiliated companies. These companies sell pharmaceuticals, health foods, cosmetics, and daily necessities, while also providing healthcare-related services.

Sugi Pharmacy operates prescription-equipped drugstores based on a total healthcare strategy. In addition to selling pharmaceuticals and health foods, it partners with local healthcare providers through prescription dispensing and home healthcare services.

Sugi Medical manages subsidiaries that operate visiting nurse services and provide business support for medical institutions. The company specializes in healthcare and health-related businesses, contributing to the enhancement of regional medical services.

S Trading operates a trading business that exports Japanese products—including pharmaceuticals, cosmetics, daily necessities, and food items—to overseas markets. It also conducts domestic wholesale operations and handles a wide range of products.

I&H operates dispensing pharmacies that provide prescription dispensing and home healthcare services. It partners with local healthcare providers to improve healthcare services and also manages subsidiaries specializing in prescription dispensing.

Management Policy

Sugi Holdings operates based on a total healthcare strategy, selling pharmaceuticals, health foods, cosmetics, and daily necessities. The company also operates prescription-filling drugstores nationwide that provide dispensing services and home medical care, collaborating with local healthcare providers.

The company established a medium-term management plan from fiscal 2022 to fiscal 2026, initially targeting 1 trillion yen in sales by fiscal 2026. However, following the acquisition of I&H Corporation as a subsidiary, the company accelerated its plan by one year and now aims to achieve 1 trillion yen in sales by fiscal 2025.

Sugi Holdings will generate synergies early in the dispensing business and strengthen its capacity to fulfill specialized prescriptions requiring advanced expertise. The company also aims to improve productivity through enhanced education of specialized personnel and optimized workforce allocation.

In the merchandise sales segment, the company will capture inbound demand through expanded product assortment for international visitors and new store openings in urban areas. Additionally, the company will reduce costs and improve productivity by promoting manufacturing-distribution-sales coordination through the Sugi Pharmacy app and digitizing store operations.

AI Chat